Activity of systemic therapies after cabozantinib (CABO) in patients (pts) with metastatic renal cell carcinoma (mRCC)

被引：1
|
作者：
Cerbone, L. [1 ]
Di Nunno, V. [2 ]
Carril, L. [1 ]
Benchimol-Zouari, A. [1 ]
Flippot, R. [1 ]
Silva, C. Alves Costa [1 ]
Colomba-Blameble, E. [1 ]
Guida, A. [3 ]
Derosa, L. [1 ]
Escudier, B. [1 ]
Albiges, L. [1 ]
机构：
[1] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Osped Bellaria, Oncol Med, Bologna, Italy
[3] Osped Santa Chiara Terni, Med & Traslat Oncol, Terni, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.815
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
743P
引用
收藏
页码：S577 / S577
页数：1
相关论文
共 50 条
  • [31] An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)
    Kao, Chester
    George, Daniel J.
    Zhang, Tian
    ONCOLOGIST, 2021, 26 (03) : E508 - E511
  • [32] Skin toxicity of sunitinib: Prospective analysis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Barete, S.
    Meric, J. B.
    Moguelet, P.
    Frances, C.
    Chosidow, O.
    Goldwasser, F.
    Rixe, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Cella, David
    Davis, Mellar P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hahn, Elizabeth A.
    Korytowsky, Beata
    Bhattacharyya, Helen
    Sandin, Rickard
    Beaumont, Jennifer L.
    Matczak, Ewa
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Phase II study of lenalidomide in patients (pts.) with metastatic renal cell carcinoma (MRCC).
    Choueiri, T. K.
    Dreicer, R.
    Rini, B. I.
    Elson, P.
    Garcia, J.
    Mekhail, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S
  • [35] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
  • [36] External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Yu, Changhong
    Kattan, Michael W.
    Hutson, Thomas E.
    Hudes, Gary R.
    Yuan, Jinyu
    Valota, Olga
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Outcomes of patients (pts) with advanced renal cell carcinoma (aRCC) treated with cabozantinib (CABO) after lenvatinib plus pembrolizumab (LEN plus PEM).
    Haro-Silerio, Jaime Ivan
    Johns, Andrew
    Moussa, Mohammad Jad
    Wang, Mindy
    Wang, Emily
    Kovitz, Craig A.
    Campbell, Matthew T.
    Jonasch, Eric
    Shah, Amishi Yogesh
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 433 - 433
  • [38] Patients (Pts) with Metastatic Renal Cell Carcinoma (mRCC) Receiving Angiogenesis Inhibitor (AI) Therapies: Treatment Efficacy and Safety in Clinical Practice
    McDermott, David
    Choueiri, Toni K.
    Clement, Jessica
    Brick, Ashley J.
    Kwabi, Christabel
    Shah, Karishma
    Antras, Lucia
    Jayawant, Sujata S.
    Wang, Si-Tien
    Luka, Andi
    Duh, Mei Sheng
    Neary, Maureen
    Oh, William K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S111 - S112
  • [39] PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC) RECEIVING ANGIOGENESIS INHIBITOR (AIS) THERAPIES: TREATMENT EFFICACY AND SAFETY IN CLINICAL PRACTICE
    McDermott, D.
    Choueiri, T. K.
    Clement, J.
    Brick, A. J.
    Kwabi, C.
    Shah, K.
    Banerjee, A.
    Duh, M. S.
    Neary, M. P.
    Oh, W. K.
    ANNALS OF ONCOLOGY, 2008, 19 : 190 - 191
  • [40] Impact of microbiome modulation on serum cytokine profile in a randomized, phase I trial of cabozantinib/nivolumab (cabo/nivo) with or without CBM588 in pts with metastatic renal cell carcinoma (mRCC)
    Li, Yu Jun
    Ebrahimi, Hedyeh
    Meza, Luis
    Malhotra, Jasnoor
    Li, Xiaochen
    Dizman, Nazli
    Dorff, Tanya
    Frankel, Paul
    Llamas-Quitiquit, Marian
    Hsu, JoAnn
    Zengin, Zeynep
    Alcantara, Marice
    Castro, Daniela
    Mercier, Benjamin
    Chawla, Neal
    Chehrazi-Raffle, Alexander
    Barragan-Carrillo, Regina
    Gillece, John
    Trent, Jeffrey
    Lee, Peter
    Parks, Thomas
    Takahashi, Motomichi
    Hayashi, Atsushi
    Caporaso, J. Gregory
    Lee, Keehoon
    Tripathi, Abhishek
    Pal, Sumanta
    ONCOLOGIST, 2024, 29 : S36 - S37
12345